Chembio Diagnostic, Inc. (CEMI) - Financial and Strategic SWOT Analysis Review

Chembio Diagnostic, Inc. (CEMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases with solutions like Dual Path Platform (DPP), which makes POC testing faster. Its DPP technology is used to treat infectious diseases such as HIV, Ebola, syphilis, Zika, malaria and febrile illness. Chembio also offers veterinary diagnostics. The company offers its products to medical laboratories and hospitals, non-governmental organizations, governmental and public health entities, medical professionals and retailers. The company distributes its products through a network of distributors worldwide. Chembio is headquartered in Medford, the US.

Chembio Diagnostic, Inc. Key Recent Developments

May 09,2017: Chembio Diagnostics Reports First Quarter 2017 Financial Results
Mar 07,2017: Chembio Diagnostics Reports 2016 Financial Results
Jan 26,2017: Chembio Appoints Sales Executives in Latin America, Africa, Asia Pacific
Nov 10,2016: Chembio Diagnostics Reports Third Quarter 2016 Financial Results
Oct 11,2016: Chembio Expands Global Commercial Operations Leadership

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Section 1 - About the Company 6
Chembio Diagnostic, Inc. - Key Facts 6
Chembio Diagnostic, Inc. - Key Employees 7
Chembio Diagnostic, Inc. - Key Employee Biographies 8
Chembio Diagnostic, Inc. - Major Products and Services 9
Chembio Diagnostic, Inc. - History 10
Chembio Diagnostic, Inc. - Company Statement 13
Chembio Diagnostic, Inc. - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 Company Analysis 16
Chembio Diagnostic, Inc. - Business Description 16
Chembio Diagnostic, Inc. - SWOT Analysis 17
SWOT Analysis - Overview 17
Chembio Diagnostic, Inc. - Strengths 17
Chembio Diagnostic, Inc. - Weaknesses 18
Chembio Diagnostic, Inc. - Opportunities 19
Chembio Diagnostic, Inc. - Threats 20
Chembio Diagnostic, Inc. - Key Competitors 21
Section 3 Company Financial Ratios 22
Financial Ratios - Capital Market Ratios 22
Financial Ratios - Annual Ratios 23
Performance Chart 26
Financial Performance 26
Financial Ratios - Interim Ratios 27
Financial Ratios - Ratio Charts 28
Section 4 Companys Lifesciences Financial Deals and Alliances 29
Chembio Diagnostic, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
Chembio Diagnostic, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30
Chembio Diagnostic, Inc., Recent Deals Summary 31
Section 5 Companys Recent Developments 32
May 09, 2017: Chembio Diagnostics Reports First Quarter 2017 Financial Results 32
Mar 07, 2017: Chembio Diagnostics Reports 2016 Financial Results 34
Jan 26, 2017: Chembio Appoints Sales Executives in Latin America, Africa, Asia Pacific 37
Nov 10, 2016: Chembio Diagnostics Reports Third Quarter 2016 Financial Results 38
Oct 11, 2016: Chembio Expands Global Commercial Operations Leadership 41
Sep 28, 2016: Chembio Awarded CDC Contract for Zika, Dengue, and Chikungunya Surveillance Testing in India, Peru, Guatemala and Haiti 42
Sep 23, 2016: Chembio Expands Exclusive Distribution Agreements with Isla Lab to Include Puerto Rico and U.S. Virgin Islands 43
Aug 25, 2016: Chembio Awarded Up to $13.2 Million U.S. Government Contract to Develop and Commercialize Point-of-Care Tests for Zika Virus 44
Aug 11, 2016: Chembio Diagnostics Reports Second Quarter 2016 Financial Results 45
Jul 25, 2016: Chembio Diagnostics Announces Preliminary Second Quarter 2016 Results 48
Section 6 Appendix 49
Methodology 49
Ratio Definitions 49
About GlobalData 53
Contact Us 53
Disclaimer 53

List Of Tables


Chembio Diagnostic, Inc., Key Facts 6
Chembio Diagnostic, Inc., Key Employees 7
Chembio Diagnostic, Inc., Key Employee Biographies 8
Chembio Diagnostic, Inc., Major Products and Services 9
Chembio Diagnostic, Inc., History 10
Chembio Diagnostic, Inc., Subsidiaries 15
Chembio Diagnostic, Inc., Key Competitors 21
Chembio Diagnostic, Inc., Ratios based on current share price 22
Chembio Diagnostic, Inc., Annual Ratios 23
Chembio Diagnostic, Inc., Annual Ratios (Cont...1) 24
Chembio Diagnostic, Inc., Annual Ratios (Cont...2) 25
Chembio Diagnostic, Inc., Interim Ratios 27
Chembio Diagnostic, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
Chembio Diagnostic, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 30
Chembio Diagnostic, Inc., Recent Deals Summary 31
Currency Codes 49
Capital Market Ratios 49
Equity Ratios 50
Profitability Ratios 50
Cost Ratios 51
Liquidity Ratios 51
Leverage Ratios 52
Efficiency Ratios 52

List Of Figures


Chembio Diagnostic, Inc., Performance Chart (2012 - 2016) 26
Chembio Diagnostic, Inc., Ratio Charts 28
Chembio Diagnostic, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 29
Chembio Diagnostic, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 30

Chembio Diagnostic, Inc. (CEMI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases

USD 250 View Report

Chembio Diagnostic, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile

Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases

USD 250 View Report

Chembio Diagnostic, Inc. (CEMI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases

USD 250 View Report

Chembio Diagnostic, Inc. (CEMI) - Medical Equipment - Deals and Alliances Profile

Chembio Diagnostic, Inc. (Chembio) develops, manufactures, markets and licenses point-of-care diagnostic (POCs) tests for the detection of infectious diseases. The company offers products to prevent the spread of infectious diseases

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available